[ad_1]
Underlines the importance of serological tests using the S1 subunit for global seroprevalence and vaccine development
PerkinElmer, Inc., a world leader committed to innovation for a healthier world, has announced that EUROIMMUN, a PerkinElmer company, has launched Anti-SARS-CoV-2 QuantiVacTM ELISA (IgG) to quantify IgG antibodies against SARS- CoV-2 antigen S1. The assay is available for countries that accept the CE mark, and the Company plans to submit an application for this product to the US Food and Drug Administration for Emergency Use Authorization (US).
This quantitative test kit applies a recombinant S1 subunit of the SARS-CoV-2 spike protein, allowing the detection of IgG antibodies. These antibodies have been the focus of vaccine development programs, as well as discussions about possible immunity in previously infected individuals. With this new ELISA assay, EUROIMMUN provides a product to support the careful evaluation of an important antibody subgroup that enables standard curve-based quantification of anti-S1 IgG antibody concentration.
“The global research and medical community is focused on having an effective SARS-CoV-2 vaccine available as soon as possible, but to do so, it is clear that quantitative antibody measurement in clinical studies will play a critical role,” he said. Dr. Wolfgang Schlumberger, Executive Director of EUROIMMUN. “EUROIMMUN trials, especially S1-based tests, are important tools for pharmaceutical laboratories conducting clinical trials. Our assays can help identify people who have been exposed to SARS-CoV-2 and can play a critical role in accurately assessing antibody status before and after infection, in antibody therapy, or in vaccination programs. “.
The ELISA QuantiVac Assay adds to the company’s extensive portfolio of COVID-19 diagnostic products and is based on the CE-marked and FDA-approved US FDA-approved semi-quantitative / qualitative anti-SARS-CoV-2 ELISA (IgG).
EUROIMMUN has increased its production of ELISA for COVID-19 diagnostics to more than three million tests per week and can supply a large number of dried blood sample collection sets for future seroprevalence and vaccine development studies. Large international reference laboratories have implemented EUROIMMUN SARS-CoV-2 tests, and the tests are being applied in an increasing number of epidemiological studies around the world.
Do you use PerkinElmer products in your laboratory? Write a review today for a chance to win a $ 400 Amazon gift card >>
